Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-9 of 9
Arthur E. Frankel
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases
Available to Purchase
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1872–1883.
Published: 09 June 2010
Journal Articles
Inhibition of Tumor Angiogenesis by the Matrix Metalloproteinase–Activated Anthrax Lethal Toxin in an Orthotopic Model of Anaplastic Thyroid Carcinoma
Available to PurchaseRandall W. Alfano, Stephen H. Leppla, Shihui Liu, Thomas H. Bugge, Janelle M. Ortiz, Terry C. Lairmore, Nicholas S. Duesbery, Ian C. Mitchell, Fiemu Nwariaku, Arthur E. Frankel
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 190–201.
Published: 12 January 2010
Includes: Supplementary data
Journal Articles
Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Available to PurchaseRandall W. Alfano, Stephen H. Leppla, Shihui Liu, Thomas H. Bugge, Meenhard Herlyn, Keiran S. Smalley, Jennifer L. Bromberg-White, Nicholas S. Duesbery, Arthur E. Frankel
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1218–1226.
Published: 15 May 2008
Includes: Supplementary data
Journal Articles
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
Available to PurchaseYan Ding, Elissa A. Boguslawski, Bree D. Berghuis, John J. Young, Zhongfa Zhang, Kim Hardy, Kyle Furge, Eric Kort, Arthur E. Frankel, Rick V. Hay, James H. Resau, Nicholas S. Duesbery
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 648–658.
Published: 17 March 2008
Includes: Supplementary data
Journal Articles
A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types
Available to PurchaseRalph J. Abi-Habib, Ravibhushan Singh, Shihui Liu, Thomas H. Bugge, Stephen H. Leppla, Arthur E. Frankel
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (10): 2556–2562.
Published: 13 October 2006
Journal Articles
Apoptosis and anthracycline cardiotoxicity
Available to Purchase
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (2): 197–199.
Published: 27 February 2006
Journal Articles
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Available to PurchaseRalph J. Abi-Habib, Jeffrey O. Urieto, Shihui Liu, Stephen H. Leppla, Nicholas S. Duesbery, Arthur E. Frankel
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (9): 1303–1310.
Published: 16 September 2005
Journal Articles
Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor–induced hepatotoxicity is mediated by Kupffer cells
Available to PurchaseMarlena M. Westcott, Ralph J. Abi-Habib, Kimberley A. Cohen, Mark C. Willingham, Shihui Liu, Thomas H. Bugge, Stephen H. Leppla, Arthur E. Frankel
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (12): 1681–1689.
Published: 04 January 2005
Journal Articles
Growth Factor Receptor Expression Varies among High-Grade Gliomas and Normal Brain: Epidermal Growth Factor Receptor Has Excellent Properties for Interstitial Fusion Protein Therapy
Available to Purchase
Journal:
Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (8): 783–787.
Published: 25 August 2003